Summary:
Fentanyl is an opioid agonist, and is indicated for the management of pain in opioid-tolerant patients, severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
Qualified Participants Must:
• Healthy males and females according to the assessment of the investigator, based on a complete medical history and physical exam.
•
Between the ages of 18-55
•
Minimum body weight of 120 lbs and BMI of 22.0-29.0 for males and 19.0-27.0 for females
•
Female subjects must meet at least one of the following criterion:
- Have used and agree to continue to use a reliable method of contraception (e.g., condom with diaphragm or cap, IUD, hormonal contraceptives) for at least 30 days before initial dosing and for at least 30 days following completion of the study.
- Surgically sterile (bilateral oophorectomy or hysterectomy, bilateral tubal ligation at least 3 months before initial dosing or Essure®
• device placement before the year 2018).
- Naturally postmenopausal (no menses) for at least 1 year before initial dosing
Qualified Participants May Receive:
Compensation for participating up to $4,000 over the study length of 3 days/ 2 nights.